6/12/2023 | BKIG | Moody's lifts Abbott Laboratories
|
3/9/2022 | BKIG | S&P lifts Abbott Laboratories
|
2/15/2022 | BKIG | Moody's boosts Abbott Labs
|
5/20/2021 | BKIG | Moody's upgrades Abbott
|
5/19/2021 | BKIG | S&P raises Abbott Labs
|
11/10/2020 | BKIG | S&P raises Abbott Labs
|
6/23/2020 | IG | Market Commentary: AerCap, CNH, Arch, Niagara Mohawk, UniCredit in primary; credit spreads firm
|
6/23/2020 | IG | Market Commentary: Morning Commentary: Niagara Mohawk, CNH, Teck, AerCap, Arch offer bonds; issues mixed
|
6/22/2020 | IG | Market Commentary: Abbott, Canadian Resources, Duke Realty price; Arch Capital on tap; credit spreads improve
|
6/22/2020 | IG | New Issue: Abbott Labs prices $1.3 billion of fixed-rate notes in two parts
|
6/22/2020 | BKIG | Moody’s assigns Abbott notes A3
|
6/22/2020 | IG | Market Commentary: Morning Commentary: Abbott, Canadian Natural Resources, Arch Capital notes on deck
|
6/22/2020 | BKIG | S&P rates Abbott notes A-
|
6/22/2020 | IG | Abbott Laboratories intends to sell fixed-rate notes in two tranches
|
12/19/2019 | IGLM | Abbott redeems all $2.85 billion 2.9% notes due 2021 at 101.972
|
11/5/2019 | BKIG | S&P ups Abbott Labs
|
5/3/2019 | BKIG | Moody’s lifts Abbott ratings
|
4/17/2019 | BKBWIG | Abbott Labs repays $10 billion of debt since 2017; more to be repaid
|
3/18/2019 | BKIG | S&P elevates Abbott Labs
|
10/29/2018 | IGLM | Abbott Laboratories, St. Jude unit redeem $4 billion of senior notes
|
9/14/2018 | BKIG | Moody’s rates Abbott Lab notes Baa1
|
9/14/2018 | BKIG | S&P gives Abbott Lab notes BBB
|
8/28/2018 | BKIG | Moody’s ups Abbott Labs debt
|
6/22/2018 | IGLM | Abbott redeems $1.3 billion portion of 2.35% notes due 2019
|
6/11/2018 | BKIG | S&P lifts Abbott Labs view to positive
|
3/22/2018 | IGLM | Abbott redeems all 5.125% notes due 2019, some 2.35% notes due 2019
|
2/13/2018 | BKIG | Moody's upgrades Abbott
|
2/12/2018 | BKCVIG | Moody’s ups Abbott Laboratories
|
11/6/2017 | EMIGLM | CFR International calls 5.125% notes due 2022 for redemption
|
3/23/2017 | IGLM | Abbott swaps out all but $194.25 million of five St. Jude note series
|
3/7/2017 | IGLM | Abbott takes in tenders of 90%-plus of each series of St. Jude notes
|
2/28/2017 | BKCVIG | Fitch gives BBB to Abbott notes
|
2/23/2017 | BKCVIG | Moody’s rates Abbott notes Baa3
|
2/21/2017 | IGLM | Abbott starts exchange offer, consent solicitation for St. Jude notes
|
1/5/2017 | BKCVIG | Moody’s drops Abbott, rates St. Jude loans Baa3
|
1/5/2017 | BKCVIG | Fitch lowers Abbott, St. Jude
|
1/4/2017 | BKIG | S&P downgrades Abbott
|
12/30/2016 | IG | Market Commentary: Outlook 2017: High-grade supply to stay robust; bond views mixed; mergers remain on forefront
|
11/23/2016 | IG | Market Commentary: Morning Commentary: High-grade primary action thins; Bank of America, Abbott mostly unchanged
|
11/22/2016 | IG | Market Commentary: KfW prices upsized $1.5 billion green notes; Duke Energy, Time Warner notes firm; Abbott eases
|
11/22/2016 | IG | Market Commentary: Morning Commentary: Pre-holiday investment-grade primary activity slows; Abbott bonds mixed
|
11/21/2016 | IG | Market Commentary: Bank of America, BP Capital, Enbridge among issuers; credit spreads firm; Abbott tightens
|
11/21/2016 | IG | Market Commentary: Morning Commentary: Enbridge, Bank of America prep deals; bonds mixed; Abbott Labs better
|
11/18/2016 | IG | Market Commentary: Light volume forecast for holiday week; Abbott, Pfizer mixed; Chevron Phillips Chemical firms
|
11/18/2016 | IG | Fitch assigns A to Abbott notes
|
11/18/2016 | IG | New Issue: Abbott Labs details $15.1 billion six-tranche sale of fixed-rate notes
|
11/17/2016 | IG | Market Commentary: Abbott Labs sells $15.1 billion notes; KeyBank, Chevron Phillips Chemical tap market
|
11/17/2016 | IG | New Issue: Abbott Laboratories sells $15.1 billion fixed-rate notes in six parts
|
11/17/2016 | BKIG | S&P rates Abbott notes A+
|
11/17/2016 | IG | Moody’s rates Abbott Laboratories notes Baa3
|
11/17/2016 | IG | Market Commentary: Morning Commentary: Abbott Labs preps six-part deal; HollyFrontier tightens; Westpac Banking flat
|
11/17/2016 | IG | Abbott Laboratories intends to sell fixed-rate notes in six tranches
|
4/28/2016 | BKIG | Abbott to use new debt to help fund $25 billion St. Jude acquisition
|
2/2/2016 | IG | Fitch might lower Abbott
|
2/1/2016 | IG | S&P reviews Abbott Laboratories
|
2/1/2016 | IG | Moody’s reviews Abbott Laboratories
|
2/1/2016 | BKBWHYIGLM | Abbott to use debt to buy Alere, will assume or refinance Alere debt
|
5/18/2015 | IG | Fitch cuts Abbott Laboratories IDR to A
|
3/5/2015 | IG | Market Commentary: Energy Transfer, Abbott, John Deere price; supply tops $60 billion; Coach, Microsoft firm
|
3/5/2015 | IG | New Issue: Abbott Laboratories prices $2.5 billion of notes in three maturities
|
3/5/2015 | IG | Moody’s lowers Teck to Baa3
|
3/5/2015 | IG | Moody’s lowers Teck to Baa3
|
3/5/2015 | IG | Moody’s rates Abbott Labs notes A2
|
3/5/2015 | IG | S&P rates Abbott notes A+
|
3/5/2015 | IG | Abbott Laboratories talks three-part notes offer for Thursday pricing
|
3/4/2015 | IG | Moody’s drops Abbott Laboratories debt to A2
|
1/15/2015 | EMIGLM | Abbott receives tenders for $1.2 million more of CFR’s 5.125% notes
|
12/30/2014 | EMIGLM | Abbott receives tenders for 97.6% of CFR’s $300 million 5.125% notes
|
12/15/2014 | EMIGLM | Abbott tenders for CFR unit’s $300 million 5.125% senior notes due 2022
|
7/15/2014 | IG | Moody's: Abbott's unchanged
|
5/20/2014 | IG | Fitch drops Abbott to negative
|
10/16/2013 | IG | Moody's: Abbott view to negative
|
12/31/2012 | IGLM | Abbott Laboratories calls $244.5 million of 5.125% notes due 2019
|
12/7/2012 | IGLM | Abbott announces prices for $2.78 billion redemption of notes series
|
11/16/2012 | IGLM | Abbott to redeem $2.77 billion of outstanding notes from four series
|
11/13/2012 | IGLM | Abbott Laboratories tallies tenders in offer for four series of notes
|
11/9/2012 | IGLM | Abbott extends tender offer for four note series, gives early results
|
11/8/2012 | IGLM | Abbott Laboratories prices tender offer for nine series of notes
|
10/26/2012 | IG | S&P lowers Abbott
|
10/26/2012 | IGLM | Abbott Laboratories launches tender offer for nine series of notes
|
10/25/2012 | IG | Moody's lifts Abbott to stable
|
6/13/2012 | IG | S&P: Abbott on negative watch
|
5/10/2012 | IG | Moody's: No change to Abbott
|
5/7/2012 | IG | Fitch: Abbott on watch
|
3/28/2012 | IG | S&P: Abbott remains on watch
|
10/19/2011 | IG | S&P places Abbott on watch
|
10/19/2011 | IG | Moody's: Abbott view negative
|
5/31/2011 | IG | Moody's: Abbott unchanged
|
5/19/2011 | IG | Fitch: Abbott to negative
|
9/22/2010 | IG | Moody's confirms Abbott Labs
|
5/25/2010 | IG | Fitch affirms Abbott
|
5/25/2010 | IG | Market Commentary: Volatility leaves new bonds absent; industrials move out; Abbott bonds mixed in secondary
|
5/24/2010 | IG | S&P rates Abbott notes AA
|
5/24/2010 | IG | Moody's gives Abbott notes A1
|
5/24/2010 | IG | Market Commentary: Abbott Labs, Georgia Power, Empire District Electric price bonds; Treasuries tighten up
|
5/24/2010 | IG | New Issue: Abbott Laboratories sells $3 billion of senior notes in five-, 10-, 30-year tranches
|
5/21/2010 | IG | Moody's might downgrade Abbott
|
5/21/2010 | IG | S&P affirms Abbott
|
9/28/2009 | IG | Moody's cuts Abbott outlook to negative
|
9/28/2009 | IG | Fitch affirms Abbott
|
9/18/2009 | IG | Market Commentary: National Life Insurance, Zions Bank price bonds; Citigroup, Barclays, Markel trade tighter
|
2/27/2009 | IG | Market Commentary: Citigroup, other bank names in focus as day lacks new deals; Citi, GE Capital gain, Chevron better
|
2/26/2009 | IG | S&P rates Abbott notes AA
|
2/26/2009 | IG | Moody's rates Abbott notes A1
|
2/26/2009 | IG | Fitch rates Abbott notes A+
|
2/26/2009 | IG | Market Commentary: Chevron, Danaher, Abbott Labs, Oneok, Alabama Power sell bonds; secondary focuses on recently priced deals
|
2/26/2009 | IG | New Issue: Abbott Laboratories sells $3 billion 10-, 30-year senior notes
|
2/12/2009 | IG | Abbott files automatic shelf registration for debt securities
|
1/20/2009 | IG | Market Commentary: Puget Sound Energy, PSEG sell bonds; market conditions, inauguration distract; financials hurt in trading
|
1/16/2009 | IG | Fitch affirms Abbott
|
1/12/2009 | IG | Moody's affirms Abbott
|
1/12/2009 | IG | S&P affirms Abbott
|
10/14/2008 | IG | S&P affirms Abbott
|
8/4/2008 | IG | Fitch lowers Abbott
|
5/5/2008 | IG | Moody's ups Abbott outlook to stable
|
11/8/2007 | IG | Market Commentary: News Corp. prices $1.25 billion 30-year bonds; upcoming holiday damps activity
|
11/6/2007 | IG | Market Commentary: Tone improves slightly, brings Abbott, Northern Trust, General Electric to market
|
11/6/2007 | IG | New Issue: Abbott Laboratories prices upsized $3.5 billion in three tranches
|
11/6/2007 | IG | S&P gives Abbott notes AA
|
11/6/2007 | IG | Moody's rates Abbott notes A1
|
11/6/2007 | IG | Fitch assigns Abbott notes AA-
|